1h-ealth - Tumblr blog

1h-ealth · 3 years

Text

The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, By Roots Analysis

Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities.

Roots Analysis has announced the addition of “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report to its list of offerings.

The report features an extensive study on the current market landscape and future of companies offering services for peptides and macrocycle drug discovery operations. The study includes in-depth analyses, highlighting the capabilities of various service / technology providers engaged in this market. Amongst other elements, the report includes:

§ A detailed assessment of the current market landscape of companies offering peptide and macrocycle drug discovery services

§ An insightful geographical benchmarking of the capabilities of companies of various sizes, highlighting the key focus areas, comparing their existing strengths both within and beyond their respective peer groups (based on geography and company size).

§ An in-depth analysis of peptide platform and library service providers, featuring information on their company details, purpose of the platform, type of peptide manufactured and platform access model.

§ Profiles of peptides and macrocycle drug discovery service providers, featuring information on the year of establishment, location of headquarters, peptide discovery service / platform portfolio, recent developments, and an informed future outlook.

§ An analysis of the partnerships that have been established in the recent past, covering mergers and acquisitions, research collaborations, R&D agreements, licensing agreements (related to both technology platforms and service providers) and other form of collaborations.

§ An analysis of proprietary display technologies developed by different drug discovery technology providers, based on the 2X2 matrix.

§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§ Type of peptides

§ Synthetic peptides

§ Biologic and recombinant peptides

§ Type of discovery steps

§ Target identification and validation

§ Hit identification

§ Lead generation

§ Lead optimization

§ Therapeutic Area

§ Oncological disorders

§ Metabolic disorders

§ Cardiovascular disorders

§ Infectious diseases

§ Urological disorders

§ Endocrine disorders

§ CNS disorders

§ Other diseases

§ Company Size

§ Small companies

§ Mid-sized companies

§ Large and very large companies

§ Key geographical regions

§ Europe

§ North America

§ Asia-Pacific and the Rest of the World

Key companies covered in the report

§ GenScript

§ JPT Peptide Technologies

§ CPC Scientific

§ IRBM

§ Creative Peptides

§ Pepscan

§ Interprotein

§ RA Pharmaceuticals

§ Pepticom

§ PeptiDream

§ Creative Biolabs

§ MeSCue-Janusys

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html

Other Recent Offerings

1. DNA-Encoded Libraries: Platforms and Services Market, 2020–2030

2. Antibody Contract Manufacturing Market, 2020 – 2030

3. Global Autoinjectors Market, 2020-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Details

Ben Johnson

+1 (415) 800 3415

[email protected]

Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com

Medium: https://medium.com/@RootsAnalysis

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/

Quora: https://rootsanalysisinsights.quora.com/

0 notes

1h-ealth · 3 years

Text

The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, By Roots Analysis

The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research

London

Roots Analysis has announced the addition of “RNAi Therapeutics Market (2nd Edition), 2019-2030” report to its list of offerings.

Significant advancements in the developmental pipeline across various oncological disorders, infectious diseases and genetic disorders have amplified the interest of various pharmaceutical establishments and have inspired research groups across the world, to focus their efforts on the development of RNAi therapeutics. Further, there are multiple pipeline candidates in mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.

To order this 350+ page report, which features 130+ figures and 190+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/rnai-therapeutics-market-2nd-edition-2019-2030/278.html

Key Market Insights

Over 170 RNAi therapeutics are currently under development

Nearly 30% of pipeline drugs are in the clinical phase, while the rest are either in the preclinical / discovery stage. The majority of pipeline drug candidates are delivered using siRNA conjugated delivery technology platform to mitigate targeted delivery to organ / cell.

More than 70% of ongoing clinical trials are being conducted in North America and Europe

In total, we came across over 100 clinical trials that have been / are being conducted across the globe. It is worth noting that around 40% of these trials were observed to be phase II studies. Further, 75% of the active clinical trials being conducted in this domain are evaluating siRNAs.

Over 36,000 patents were filed / granted related to RNAi therapeutics since 2014

Majority of these were patent applications (59%), followed by granted patents (40%). It is worth highlighting that both industry and non-industry players are actively involved in this domain. However, majority of the patents related to RNAi therapeutics were filed / granted by industry players (58%).

USD 5.4+ billion invested by both private and public investors, since 2014

Around USD 3 billion was raised through secondary offerings, representing more than 50% of the total capital raised by industry players till July 2019. Further, there have been five instances of debt financing, accounting for more than USD 844 million in financing of RNAi therapeutics related initiatives.

Around 65 partnerships were inked since 2014

Maximum number of deals were reported in 2018. Around 30% of the deals were related to the R&D agreements; this was followed by technology licensing agreements (27%).

RNAi therapeutics market is anticipated to increase at a CAGR of over 45% between 2019-2030

This growth is anticipated to be primarily driven by the target specificity of the drug candidates. North America (primarily the US) are expected to capture the majority share by 2030.

To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/278/request-sample.html

Key Questions Answered

§ Who are the leading industry players in this market?

§ What are the clinical conditions for which RNAi therapeutics are being developed?

§ Who are the key investors in the RNAi therapeutics market?

§ What kind of commercialization strategies are being adopted by RNAi therapeutics developers?

§ What are the different promotional and reimbursement strategies used for RNAi therapeutics?

§ What are the prevalent R&D trends related to RNAi therapeutics?

§ What are the various delivery / technology platforms that are being used for the development of RNAi therapeutics?

§ What kind of partnership models are used by stakeholders in this industry?

§ Who are the key service providers in this field of therapeutics?

§ How is the current and future market opportunity likely to be distributed across key market segments?

The USD 10 billion (by 2030) financial opportunity within the RNAi therapeutics market has been analyzed across the following segments:

§ Key therapeutic areas

§ Oncological disorders

§ Infectious diseases

§ Genetic disorders

§ Ophthalmic disorders

§ Hepatic disorders

§ Respiratory disorders

§ Type of RNAi molecule

§ siRNA

§ miRNA

§ shRNA

§ sshRNA

§ DNA

§ Route of administration

§ Subcutaneous

§ Intravenous

§ Intradermal

§ Intratumoral

§ Intravitreal

§ Oral

§ Intramuscular

§ Key geographical regions

§ North America

§ Europe

§ Asia Pacific and the Rest of the World

§ Leading Players

The report features inputs from eminent industry stakeholder(s), according to whom RNAi therapeutics are promising domain of pharmaceutical industry. The report includes detailed transcripts of discussions held with the following expert(s):

§ Amotz Shemi (Chief Executive Officer, Silenseed)

The research covers brief profiles, featuring an overview of the therapy, current development status and clinical results. Each profile includes information on therapeutic area, indication, targeted gene, route of administration, special designations, mechanism of action, dosage, patent portfolio, technology portfolio, clinical trials and recent developments (if available).

§ Quark Pharmaceuticals

§ Alnylam Pharmaceuticals

§ Dicerna Pharmaceuticals

§ Souzhou Ribo Life Sciences

§ Olix Pharmaceuticals

§ Sirnaomics

§ Ariz Precision Medicine

§ Arrowhead Pharmaceuticals

§ Gradalis

§ Benitec Biopharma

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/rnai-therapeutics-market-2nd-edition-2019-2030/278.html or email [email protected]

You may also be interested in the following titles:

1. Gene Therapy Market (3rd Edition), 2019-2030

2. Global T-Cell (CAR-T, TCR and TIL) Therapy Market (4th Edition), 2019-2030

3. Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030

About Roots Analysis

Contact Details

Ben Johnson

+1 (415) 800 3415

[email protected]

Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com

Medium: https://medium.com/@RootsAnalysis

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/

Quora:

https://rootsanalysisinsights.quora.com/

0 notes

1h-ealth · 3 years

Text

The proteome profiling services market is growing at a CAGR of 15%, claims Roots Analysis

Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise

Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.”

The report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:

§ A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider, year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling, service(s) offered for proteome profiling, other service(s) offered, type of product profiled and type of sample(s) used.

§ Detailed profiles of prominent proteome profiling players (shortlisted on the basis of the number of pipeline services).

§ An analysis of the partnerships that have been established in this domain, in the recent past.

§ A competitiveness analysis of proteome profiling services, featuring insightful pictorial summaries and representations.

§ An elaborate discussion on various factors contributing to the high price of proteome profiling.

§ A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution, under a comprehensive SWOT framework.

§ A detailed review of the impact of the COVID-19 pandemic on the overall proteome profiling services market.

§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

§ Application Area

§ Drug Discovery

§ Disease Diagnosis

§ Others

§ Type of Sponsor(s)

§ Contract Research Organizations

§ Pharmaceutical Companies

§ Research and Academic Institutes

§ Key Geographical Regions

§ North America

§ Europe

§ Asia-Pacific and the Rest of the World

Key companies covered in the report

§ Biognosys

§ BGI

§ Bioproximity

§ Cell Signaling Technology

§ Creative Biolabs

§ Creative Proteomics

§ Cytomics

§ i-DNA Biotechnology

§ NMI TT Pharmaservices

§ Poochon Scientific

§ Proteomics International

§ Proteome Factory

§ Sciomics

§ tebu-bio

§ VProteomics

For more information please click on the following link:

https://www.rootsanalysis.com/reports/proteome-profiling-services.html

Other Recent Offerings

1. Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030

2. Peptide Therapeutics: Contract API Manufacturing Market, 2020 - 2030

3. Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030

About Roots Analysis

Contact Details

Ben Johnson

+1 (415) 800 3415

[email protected]

Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com

Medium: https://medium.com/@RootsAnalysis

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/

Quora:

https://rootsanalysisinsights.quora.com/

0 notes

1h-ealth · 3 years

Text

Digital Health Market: Focus on Digital Therapeutics by Roots Analysis

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions.

Roots Analysis is pleased to announce the publication of its recent study titled, “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these solutions over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:

§ A detailed assessment of the current market landscape of companies engaged in the development of digital therapeutic solutions.

§ A detailed product competitiveness analysis of key industry players for the most popular therapeutic areas taking into consideration the strength of product portfolio and key product specific parameters.

§ Elaborate profiles of key industry players that offer a several digital therapeutic solutions (shortlisted on the basis of the product portfolio).

§ An insightful competitiveness analysis featuring a four-dimensional bubble chart, highlighting the key players in this domain.

§ A detailed analysis of more than 220 completed, ongoing and planned clinical studies of various digital therapeutic solutions, based on the several relevant parameters.

§ An analysis of the investments made in the period between 2009 and 2020 at various stages of development in companies that are engaged in this field.

§ An analysis of the partnerships that have been inked by stakeholders in this domain, in the period between 2008 and 2020.

§ A detailed analysis of the various business models and go-to-market strategies adopted by companies involved in this space.

§ A Bowman’s Strategy Clock framework in order to analyze the competitive position of various companies in the marketplace, taking into consideration the prices and features of their products.

§ An insightful discussion on the impact of COVID-19 pandemic on the overall digital therapeutic solutions market, and the key initiatives undertaken by big pharma players.

§ A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution.

§ An informative analysis of contemporary Google Trends in the time period between 2015 and 2020 (till July) and insights from the recent news articles related digital therapeutic solutions.

§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§ Type of Solution

§ Standalone Software Application

§ Software Application + Device + Personal Coach

§ Software Application + Device + AI Support

§ Software Application + Device

§ Software Application + AI Support

§ Software Application + Personal Coach

§ Other Types of Solutions

§ Purpose of Solution

§ Medication Replacement

§ Medication Augmentation

§ Type of Therapy

§ Curative

§ Preventive

§ Business Model

§ Business to Consumer (Patients and Caregivers)

§ Business to Business (Healthcare Providers, Payers, Employers and Pharmaceutical Companies)

§ Therapeutic Areas

§ Cardiovascular Disorders

§ Chronic Pain

§ Mental Health Problems

§ Metabolic Disorders

§ Neurological Disorders

§ Respiratory Disorders

§ Sleep Disorders

§ Substance Use Disorders

§ Others

§ Key Geographical Regions

§ North America

§ Europe

§ Asia-Pacific

§ Rest of the world

Key companies covered in the report - https://www.rootsanalysis.com/reports/208/request-sample.html

§ Akili Interactive

§ Beats Medical

§ Big Health

§ Bold Health

§ Click Therapeutics

§ CureApp

§ dreem

§ Ehave

§ Ginger

§ Happify Health

§ inMotion VR

§ Kaia Health

§ Lark Health

§ Mahana Therapeutics

§ MindMaze

§ Noom

§ NOVOSI

§ Omada Health

§ Palo Alto Health Sciences

§ Pear Therapeutics

§ Vida Health

§ Welldoc

§ ZOLL Medical

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/digital-health-market-focus-on-digital-therapeutic-monitoring-and-diag/208.html

Other Recent Offerings

1. AR / VR Based Healthcare Digital Marketing Service Providers Market, 2020-2030

2. AI-Based Clinical Trial Solution Providers Market, 2020-2030

3. Global Handheld Ultrasound Imaging Devices Market, 2020-2030

About Roots Analysis

Contact Details

Ben Johnson

+1 (415) 800 3415

[email protected]

Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com

Medium: https://medium.com/@RootsAnalysis

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/

Quora: https://rootsanalysisinsights.quora.com/

1 note · View note